Reply To: Accelerating Phase 1 timelines as much as possible


Bhavin Patel
Participant

Reply To: Accelerating Phase 1 timelines as much as possible

If only sending unlabeled brite stock to clinical site and site labels it clinically, what has been the experience on TMF filing requirements from sponsor perspective and related to regulations?